Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | MLYCD | O95822 | 1/20 | 0.36 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22529835 | 0.92 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL27699057 | 0.86 | CHRNB2 (0.36) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL3868314 | 0.85 | CHRNB2 (0.41) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL4889483 | 0.84 | EGLN2 (0.37) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL20534746 | 0.83 | CHRNB2 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL38651897 | 0.81 | MLYCD (0.50) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL19418096 | 0.81 | CHRNB2 (0.41) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL1008386 | 0.81 | PDK1 (0.40) | ABCB1ALDH1A1MAPTKMT2A | |
| SCHEMBL20534652 | 0.80 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 | |
| SCHEMBL14266578 | 0.79 | MLYCD (0.43) | CHRNB2CHRNB4CHRNA3CHRNA4GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12486240-B2 | Oxadiazole compounds for controlling or preventing phytopathogenic fungi | PI INDUSTRIES LTD. (IN) | 2025-12-02 | — | — | US | disclosed |
| EP-3953340-B1 | NOVEL OXADIAZOLE COMPOUNDS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI | PI INDUSTRIES LTD (IN) | 2023-08-02 | — | — | EP | disclosed |
| US-20220135531-A1 | NOVEL OXADIAZOLE COMPOUNDS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI | PI INDUSTRIES LTD. (IN) | 2022-05-05 | — | — | US | disclosed |
| EP-3953340-A1 | NOVEL OXADIAZOLE COMPOUNDS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI | PI Industries Ltd. (IN) | 2022-02-16 | — | — | EP | disclosed |
| EP-1482940-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Pharmacia Corporation (US) | 2004-12-08 | — | — | EP | disclosed |
| US-20040082585-A1 | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade | PHARMACIA CORPORATION | 2004-04-29 | — | — | US | disclosed |
| WO-2003028729-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486240-B2 | Oxadiazole compounds for controlling or preventing phytopathogenic fungi | OXA1L, CYP51A1, ERG28 | CHRNB2 4799/4885CHRNB4 4798/4885CHRNA3 4040/4885 |
| US-20220135531-A1 | NOVEL OXADIAZOLE COMPOUNDS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI | OXA1L, FBXL19, ERG28 | CHRNB2 4827/4885CHRNB4 4832/4885CHRNA3 4385/4885 |
| US-20040082585-A1 | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade | TFPI, F2, PLG | CHRNB2 4852/4885CHRNB4 4840/4885CHRNA3 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.